The FDA has granted approval for the ANDA of Lupin’s Sacubitril and Valsartan Tablets for heart failure patients.

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

Lupin has received tentative approval from the USFDA to market a generic HIV drug in the US under PEPFAR. The drug, made at ...

Today’s stock recommendations feature a mix of picks from the pharmaceutical, insurance, and chemicals sectors.

Lupin receives US FDA approval for sacubitril and valsartan tablets: Our Bureau, Mumbai Friday, January 24, 2025, 15:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) announc ...

Lupin receives US FDA marketing nod for generic Triumeq PD tablets for oral suspension to trteat HIV-1 infection: Our Bureau, Mumbai Friday, January 24, 2025, 14:15 Hrs [IST] Glob ...

The US healthcare system under Trump 2.0 are likely to benefit Indian players, except for the push for increased US drug ...

Reuters Nifty continues to climb a wall of worry as it looks to be in the final leg of its rally before heading for a ...

The Alabama Department of Public Health issued a statement about its current investigation into certain “adverse events” ...

Mirroring the Sensex, NSE Nifty50 also ended lower by 113.15 points or 0.49 per cent at 23,092.20. The Nifty50 recorded a day ...

Sun Pharma to Dr. Reddy's, here is what analysts expect for Indian pharma firms in the third quarter of fiscal 2025.